The DNA methylation level of S100A8 decreases in hepatocellular carcinoma tissues compared to that in adjacent normal tissues, which is closely related to reduced overall and progression-free survival periods, indicating that S100A8 DNA methylation could also be a useful diagnostic and prognostic marker (Liu K. et al., 2016). This evidence concerns the gene S100A8 and hepatocellular carcinoma.